CBL and hepatocellular carcinoma: Our results confirmed that SPRY2 is indirectly regulated by miR-22-3p in HCC cells, and through the miR-22-3p/CBL/SPRY2 axis, miR-22-3p suppresses EMT, migration, and invasion of HCC cells.